| HGNC Family | Non-coding RNAs |
| Name | microRNA 125a |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nmiR‑125a is a versatile non‑coding RNA whose proper biogenesis is critical for its regulatory functions. Genetic variations such as a single‐nucleotide polymorphism in the miR‑125a precursor can impair processing from primary to precursor forms and consequently reduce its translational repression of target genes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In breast cancer, miR‑125a represses the oncogenic RNA‑binding protein HuR, thereby inhibiting cell growth and migration"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ", while in ovarian cancer, downregulation of miR‑125a by EGFR signaling contributes to epithelial‑to‑mesenchymal transition (EMT) via diminished ARID3B regulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In non‑small‑cell lung cancer (NSCLC), distinct mature isoforms of miR‑125a (–3p/–5p) modulate invasive and migratory behaviors."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nmiR‑125a also regulates multiple oncogenic signaling pathways in diverse malignancies. In glioblastoma, the microRNA together with miR‑29b directly targets PDPN to impede cell proliferation and invasion"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", and in gastric cancer it functions as a tumor suppressor by modulating the ERBB2 pathway."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Its antiviral activity is highlighted by its ability to interact with hepatitis B virus genomic sequences, thereby suppressing viral antigen expression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In lung cancer cells, miR‑125a‑5p has been shown to induce apoptosis in a p53‑dependent manner"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", while in diffuse large B‑cell lymphoma overexpression of miR‑125a (often together with its paralog miR‑125b) targets the negative NF‑κB regulator TNFAIP3, thereby enhancing NF‑κB signaling and contributing to lymphomagenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond oncogenic signaling, aberrant miR‑125a expression influences the tumor microenvironment, immune balance, and diagnostic biomarker potential. Although its role in hepatocellular carcinoma remains to be fully elucidated"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": ", miR‑125a‑5p is a key regulator of blood–brain barrier tightness and immune cell efflux in neurological disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": " In NSCLC, circulating miR‑125a‑5p levels have been proposed as a promising diagnostic biomarker"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": ", while its restoration in colon cancer cells promotes apoptosis via downregulation of anti‑apoptotic factors."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": " Moreover, reduced miR‑125a expression in cervical cancer correlates with increased STAT3 signaling and aggressive tumor behavior"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ", and its downregulation in autoimmune conditions destabilizes regulatory T‑cell homeostasis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": " Altered miR‑125a levels have additionally been linked to endothelial dysfunction in pediatric cardiovascular risk"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": "and to modulation of cancer stem cell properties in breast cancer via indirect regulation of the LIFR–TAZ axis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nmiR‑125a further impacts cellular metabolism and apoptotic pathways, underscoring its multifaceted regulatory role. For instance, in esophageal squamous cell carcinoma, a miR‑125a–containing cluster is implicated in pro‑metastatic signaling through targeting of ARID3A, a process transcriptionally modulated by ZEB1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": " In addition, miR‑125a‑3p downregulates Fyn kinase activity, leading to cell cycle arrest and reduced migration."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": " In pancreatic cancer, miR‑125a attenuates mitochondrial fission, thereby reducing oxidative stress and curtailing pro‑survival signaling"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": ", and in atherosclerosis, miR‑125a‑5p suppresses TET2 expression to trigger mitochondrial dysfunction, activate inflammasomes, and induce pyroptosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": " Furthermore, circulating exosomal miR‑125a‑3p has been identified as a promising diagnostic marker for early‐stage colon cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ranhui Duan, Changhui Pak, Peng Jin "}, {"type": "b", "children": [{"type": "t", "text": "Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddm062"}], "href": "https://doi.org/10.1093/hmg/ddm062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17400653"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17400653"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Xu Guo, Yuehan Wu, Rebecca S Hartley "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-125a represses cell growth by targeting HuR in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "RNA Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/rna.6.5.10079"}], "href": "https://doi.org/10.4161/rna.6.5.10079"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19875930"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19875930"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Karen D Cowden Dahl, Richard Dahl, Jessica N Kruichak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1593/neo.09942"}], "href": "https://doi.org/10.1593/neo.09942"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19881956"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19881956"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Lili Jiang, Qin Huang, Siyang Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-10-318"}], "href": "https://doi.org/10.1186/1471-2407-10-318"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20569443"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20569443"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Maria Angelica Cortez, Milena Sabrina Nicoloso, Masayoshi Shimizu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.20808"}], "href": "https://doi.org/10.1002/gcc.20808"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20665731"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20665731"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Naohiro Nishida, Koshi Mimori, Muller Fabbri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-10-2132"}], "href": "https://doi.org/10.1158/1078-0432.CCR-10-2132"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21220473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21220473"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Nicoletta Potenza, Umberto Papa, Nicola Mosca, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkr067"}], "href": "https://doi.org/10.1093/nar/gkr067"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21317190"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21317190"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Lili Jiang, Qin Huang, Jihong Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Lung Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/01902148.2010.492068"}], "href": "https://doi.org/10.3109/01902148.2010.492068"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21777146"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21777146"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Sang-Woo Kim, Kumaraguruparan Ramasamy, Hakim Bouamar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1200081109"}], "href": "https://doi.org/10.1073/pnas.1200081109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22550173"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22550173"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Qian Bi, Shanhong Tang, Lin Xia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0040169"}], "href": "https://doi.org/10.1371/journal.pone.0040169"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22768249"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22768249"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Arie Reijerkerk, M Alejandro Lopez-Ramirez, Bert van Het Hof, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.3965-12.2013"}], "href": "https://doi.org/10.1523/JNEUROSCI.3965-12.2013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23595744"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23595744"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Rui-Juan Wang, Yan-Hua Zheng, Ping Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25755772"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25755772"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Zhiguo Tong, Nan Liu, Luoqiang Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2015.07.036"}], "href": "https://doi.org/10.1016/j.biopha.2015.07.036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26297542"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26297542"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Zhongyi Fan, Hanzhi Cui, Xiaojie Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.4457"}], "href": "https://doi.org/10.18632/oncotarget.4457"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26389681"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26389681"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Wen Pan, Shu Zhu, Dai Dai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms8096"}], "href": "https://doi.org/10.1038/ncomms8096"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25963922"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25963922"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Abdelnaby Khalyfa, Leila Kheirandish-Gozal, Rakesh Bhattacharjee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating microRNAs as Potential Biomarkers of Endothelial Dysfunction in Obese Children."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Chest (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1378/chest.15-0799"}], "href": "https://doi.org/10.1378/chest.15-0799"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26270249"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26270249"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Sushmita Bose Nandy, Arunkumar Arumugam, Ramadevi Subramani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.3953"}], "href": "https://doi.org/10.18632/oncotarget.3953"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25962054"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25962054"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jianlin Ma, Yun Zhan, Zhipeng Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ZEB1 induced miR-99b/let-7e/miR-125a cluster promotes invasion and metastasis in esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2017.04.006"}], "href": "https://doi.org/10.1016/j.canlet.2017.04.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28408353"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28408353"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Lihi Ninio-Many, Hadas Grossman, Noam Shomron, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.123414"}], "href": "https://doi.org/10.1242/jcs.123414"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23606749"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23606749"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Lichao Pan, Lin Zhou, Weijia Yin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-125a induces apoptosis, metabolism disorder and migrationimpairment in pancreatic cancer cells by targeting Mfn2-related mitochondrial fission."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2018.4380"}], "href": "https://doi.org/10.3892/ijo.2018.4380"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29749475"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29749475"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Zeng Zhaolin, Chen Jiaojiao, Wu Peng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p/TET2 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.27509"}], "href": "https://doi.org/10.1002/jcp.27509"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30370524"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30370524"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Jing Wang, Feihu Yan, Qi Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-04386-1"}], "href": "https://doi.org/10.1038/s41598-017-04386-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28646161"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28646161"}]}]}]}
|
| Synonyms | MIR-125A, MIRNA125A, MIRN125A |
| NCBI Gene ID | 406910 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR125A has 830 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 18 datasets.
Click the + buttons to view associations for MIR125A from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR125A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR125A gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR125A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR125A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR125A gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR125A gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR125A gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR125A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GAD Gene-Disease Associations | diseases associated with MIR125A gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR125A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR125A from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MIR125A gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MIR125A gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR125A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MIR125A gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR125A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR125A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| WikiPathways Pathways 2014 | pathways involving MIR125A protein from the Wikipathways Pathways 2014 dataset. | |